Literature DB >> 35257270

LncRNA XIST facilitates hypoxia-induced myocardial cell injury through targeting miR-191-5p/TRAF3 axis.

Yonghong Wang1, Yanfei Liu1, Aike Fei1, Zaixin Yu2.   

Abstract

Myocardial infarction is one of the most lethal diseases in cardiovascular diseases. In the present work, we aimed to elucidate the molecular and functional association long non-coding RNA (lncRNA) X-inactive specific transcript (XIST), microRNA (miR)-191-5p, and TNF receptor-associated factor 3 (TRAF3). Human cardiomyocyte primary cells (HCMs) were stimulated by hypoxia to establish a model of myocardial injury in vitro. The relative expressions of XIST, miR-191-5p, and TRAF3 were measured using quantitative real-time polymerase chain reaction (qRT-PCR) assay. The capabilities of proliferation and apoptosis were determined using cell counting kit (CCK-8) and flow cytometry assays, respectively. The molecular interactions were verified using dual luciferase assay. The protein contents of TRAF3, Bcl-2, and Bax were calculated using western blot assay. XIST was significantly increased, but miR-191-5p was reduced in hypoxia-treated HCMs compared to that in control group. Either downregulated XIST or enforced miR-191-5p markedly enhanced cell viability and restrained cell apoptotic rate in hypoxia-treated HCMs. Mechanistically, XIST directly interacted with miR-191-5p to competitive releasing TRAF3 expression. Importantly, overexpression of TRAF3 dramatically diminished the protective effects of XIST knockdown on hypoxia-triggered HCMs injury. Collectively, our data elucidated a novel "lncRNA XIST/miR-191-5p/TRAF3" molecular network in vitro, indicating that the reduced lncRNA XIST-protected HCMs from hypoxia-induced cell injury by regulating miR-191-5p/TRAF3 signaling, which might provide some convincing evidences for further understanding the influences of "lncRNA-miRNA-mRNA" network in the development of MI.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Hypoxia; Myocardial infarction; TRAF3; XIST; miR-191-5p

Mesh:

Substances:

Year:  2022        PMID: 35257270     DOI: 10.1007/s11010-022-04385-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

Review 1.  Timing of coronary artery bypass graft surgery following acute myocardial infarction: a critical literature review.

Authors:  Arthur W Crossman; Harry J D'Agostino; Stephen A Geraci
Journal:  Clin Cardiol       Date:  2002-09       Impact factor: 2.882

Review 2.  Regional systems-of-care for primary percutaneous coronary intervention in ST-elevation myocardial infarction.

Authors:  Jacob Thorsted Sørensen; Michael Maeng
Journal:  Coron Artery Dis       Date:  2015-12       Impact factor: 1.439

Review 3.  X-Chromosome Inactivation: A Crossroads Between Chromosome Architecture and Gene Regulation.

Authors:  Rafael Galupa; Edith Heard
Journal:  Annu Rev Genet       Date:  2018-09-26       Impact factor: 16.830

4.  Managing complications in acute myocardial infarction.

Authors:  Ajit S Mullasari; P Balaji; Tenzing Khando
Journal:  J Assoc Physicians India       Date:  2011-12

5.  Myocardial infarction biomarker discovery with integrated gene expression, pathways and biological networks analysis.

Authors:  Abdulrahman Mujalli; Babajan Banaganapalli; Nuha Mohammad Alrayes; Noor A Shaik; Ramu Elango; Jumana Y Al-Aama
Journal:  Genomics       Date:  2020-09-11       Impact factor: 5.736

6.  Conditional Inference Tree for Multiple Gene-Environment Interactions on Myocardial Infarction.

Authors:  Zhijun Wu; Xiuxiu Su; Haihui Sheng; Yanjia Chen; Xiang Gao; Le Bao; Wei Jin
Journal:  Arch Med Res       Date:  2017-12-16       Impact factor: 2.235

7.  Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.

Authors:  Ori Ben-Yehuda; Shmuel Chen; Björn Redfors; Thomas McAndrew; Aaron Crowley; Ioanna Kosmidou; David E Kandzari; John D Puskas; Marie-Claude Morice; David P Taggart; Martin B Leon; Nicholas J Lembo; W Morris Brown; Charles A Simonton; Ovidiu Dressler; Arie Pieter Kappetein; Joseph F Sabik; Patrick W Serruys; Gregg W Stone
Journal:  Eur Heart J       Date:  2019-06-21       Impact factor: 29.983

8.  LncRNA CAIF inhibits autophagy and attenuates myocardial infarction by blocking p53-mediated myocardin transcription.

Authors:  Cui-Yun Liu; Yu-Hui Zhang; Rui-Bei Li; Lu-Yu Zhou; Tao An; Rong-Cheng Zhang; Mei Zhai; Yan Huang; Kao-Wen Yan; Yan-Han Dong; Murugavel Ponnusamy; Chan Shan; Sheng Xu; Qi Wang; Yan-Hui Zhang; Jian Zhang; Kun Wang
Journal:  Nat Commun       Date:  2018-01-02       Impact factor: 14.919

9.  Exercise and incidence of myocardial infarction, stroke, hypertension, type 2 diabetes and site-specific cancers: prospective cohort study of 257 854 adults in South Korea.

Authors:  Youngwon Kim; Stephen Sharp; Semi Hwang; Sun Ha Jee
Journal:  BMJ Open       Date:  2019-03-13       Impact factor: 2.692

10.  LncRNA H19 ameliorates myocardial infarction-induced myocardial injury and maladaptive cardiac remodelling by regulating KDM3A.

Authors:  Bo-Fang Zhang; Hong Jiang; Jing Chen; Qi Hu; Shuo Yang; Xiao-Pei Liu; Gen Liu
Journal:  J Cell Mol Med       Date:  2019-11-21       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.